FDA 483 data is just the tip of the iceberg
AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

483 Livzon Group Fuzhou Fuxing Pharmaceutical, Aug 2018

$179 - Available for instant download

FDA investigators audited the Livzon Group Fuzhou Fuxing Pharmaceutical - Fuzhou, China facility and issued inspectional observation (via FDA 483) on 03 Aug 2018.

Product Details

  • Inspection end: 03 Aug 2018
  • Location: Fuzhou, China
  • FEI: 3006772356
Livzon Group Fuzhou Fuxing Pharmaceutical FDA inspection 483 Aug 2018

Related Products